Asymmetric dimethylarginine levels and diabetes duration: Relationship with measures of subclinical atherosclerosis and cardiac function in children and adolescents with Type 1 diabetes

Creative Commons License

ERSOY B., Eroglu N., Cetin M., ONUR E., ÖZKOL M., COŞKUN Ş.

DIABETES & VASCULAR DISEASE RESEARCH, vol.15, no.3, pp.196-203, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 15 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.1177/1479164118757921
  • Journal Name: DIABETES & VASCULAR DISEASE RESEARCH
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.196-203
  • Karadeniz Technical University Affiliated: Yes

Abstract

Aims: We aimed to evaluate asymmetric dimethylarginine levels in young patients with Type 1 diabetes mellitus according to diabetes duration and to examine the relationship between these levels and measures of atherosclerosis and myocardial function.